Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02514551
Title A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Paclitaxel

Ramucirumab

Age Groups: adult
Covered Countries USA | ITA | ESP | DEU | CAN | BEL


No variant requirements are available.